Autocitrullination confers monocyte chemotactic properties to peptidylarginine deiminase 4

Autocitrullination confers monocyte chemotactic properties to peptidylarginine deiminase 4

Abstract Peptidylarginine deiminase 4 (PAD4) contributes to the production of citrullinated proteins as autoantigens for anti-citrullinated protein antibodies (ACPAs) in rheumatoid arthritis (RA). PAD4 can also self-deiminate via autocitrullination. However, the role of this process in RA pathogenes...

Full description

Bibliographic Details
Main Authors:	Ken Yoshida, Haruyasu Ito, Daisaburo Kurosaka, Ryo Ikeda, Kentaro Noda, Mitsuru Saito, Daitaro Kurosaka
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-05-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-023-34469-1

Similar Items

IMMUNISATION WITH RECOMBINANT AUTOCITRULLINATED PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEIMINASE INDUCES AUTOIMMUNITY TO ENOLASE AND ARTHRITIS IN DBA/1 MICE
by: Quirke, A, et al.
Published: (2013)

Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: A potential mechanism for breaching immunologic tolerance in rheumatoid arthritis
by: Quirke, A, et al.
Published: (2014)

Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.
by: Quirke, A, et al.
Published: (2014)

Angiogenesis and VEGF-expressing cells are identified predominantly in the fascia rather than in the muscle during the early phase of dermatomyositis
by: Ken Yoshida, et al.
Published: (2017-12-01)

In vivo expression of peptidylarginine deiminase in Drosophila melanogaster.
by: Olena Mahneva, et al.
Published: (2020-01-01)

Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis
by: M. Kristen Demoruelle, et al.
Published: (2021-06-01)

Porphyromonas gingivalis peptidylarginine deiminase in the aetiology of rheumatoid arthritis
by: Montgomery, AB
Published: (2016)

Expression of Peptidylarginine Deiminase Type 4 in Ovarian Tumors
by: Lin Wang, Xiaotian Chang, Guangying Yuan, Yan Zhao, Pengcheng Wang
Published: (2010-01-01)

Intramuscular lesions in musculoskeletal MRI as a favourable prognostic sign in patients with anti-MDA5 antibody-positive dermatomyositis
by: Taro Ukichi, et al.
Published: (2023-07-01)

Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses
by: Aisha M. Mergaert, et al.
Published: (2022-01-01)

Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis
by: Yudong Liu, et al.
Published: (2018-07-01)

PEPTIDYLARGININE DEIMINASES AS DRUG TARGETS IN NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY
by: Sigrun eLange, et al.
Published: (2016-02-01)

Reactive oxygen species inhibit catalytic activity of peptidylarginine deiminase
by: Dres Damgaard, et al.
Published: (2017-01-01)

Peptidylarginine Deiminase 2 in Host Immunity: Current Insights and Perspectives
by: Zhenyu Wu, et al.
Published: (2021-11-01)

Candida albicans-Induced NETosis Is Independent of Peptidylarginine Deiminase 4
by: Eva Guiducci, et al.
Published: (2018-07-01)

Clinical Images: Muscular lesion in antineutrophil cytoplasmic antibody–associated vasculitis detected using dynamic contrast–enhanced magnetic resonance imaging
by: Kentaro Noda, et al.
Published: (2024-04-01)

Impact of posterior femoral condylar cartilage and posterior intercondylar distance on rotation of femoral component in total knee arthroplasty
by: Teruyuki Miyasaka, et al.
Published: (2020-07-01)

Potential Role of Peptidylarginine Deiminase Enzymes and Protein Citrullination in Cancer Pathogenesis
by: Sunish Mohanan, et al.
Published: (2012-01-01)

Intrinsic function of the peptidylarginine deiminase PADI4 is dispensable for normal haematopoiesis
by: Christine Young, et al.
Published: (2022-06-01)

Functional role of dimerization of human peptidylarginine deiminase 4 (PAD4).
by: Yi-Liang Liu, et al.
Published: (2011-01-01)

Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis
by: Montgomery, AB, et al.
Published: (2015)

Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?
by: Mangat, P, et al.
Published: (2010)

AUTODEIMINATION OF PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEIMINASE: A NOVEL ANTIGEN IN RHEUMATOID ARTHRITIS
by: Lugli, E, et al.
Published: (2012)

Insight into Neutrophil Extracellular Traps through Systematic Evaluation of Citrullination and Peptidylarginine Deiminases
by: Caitlyn L. Holmes, et al.
Published: (2019-01-01)

Expression of peptidylarginine deiminase 2 and 4 in malignant mesothelioma and its clinical significance
by: GAN Yihan, SHEN Wei, CHEN Yitong, YAN Kaili, HU Shuaiyue, JIANG Zhaoqiang, YING Shibo
Published: (2023-07-01)

Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis
by: Erika Darrah, et al.
Published: (2018-11-01)

There's no place like OM: Vesicular sorting and secretion of the peptidylarginine deiminase of Porphyromonas gingivalis
by: Giorgio Gabarrini, et al.
Published: (2018-12-01)

Porphyromonas gingivalis exacerbates ulcerative colitis via Porphyromonas gingivalis peptidylarginine deiminase
by: Xida Zhao, et al.
Published: (2021-09-01)

Increased peptidylarginine deiminases expression during the macrophage differentiation and participated inflammatory responses
by: Ning-Sheng Lai, et al.
Published: (2019-04-01)

Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis
by: Laura C. Cappelli, et al.
Published: (2018-03-01)

A cyclic peptide toolkit reveals mechanistic principles of peptidylarginine deiminase IV regulation
by: M. Teresa Bertran, et al.
Published: (2024-11-01)

Peptidylarginine deiminase 3 modulates response to neratinib in HER2 positive breast cancer
by: Inés Romero-Pérez, et al.
Published: (2024-08-01)

Probing the Roles of Calcium-Binding Sites during the Folding of Human Peptidylarginine Deiminase 4
by: Yi-Liang Liu, et al.
Published: (2017-05-01)

Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice
by: Jessica Cedervall, et al.
Published: (2017-08-01)

Peptidylarginine deiminase 2 has potential as both a biomarker and therapeutic target of sepsis
by: Yuzi Tian, et al.
Published: (2020-10-01)

A Secreted Bacterial Peptidylarginine Deiminase Can Neutralize Human Innate Immune Defenses
by: Tim Stobernack, et al.
Published: (2018-11-01)

Peptidylarginine deiminase inhibitors reduce bacterial membrane vesicle release and sensitize bacteria to antibiotic treatment
by: Kosgodage, Uchini S., et al.
Published: (2019)

A pilot study on peptidylarginine deiminases and protein deimination in animal cancers across vertebrate species
by: Inal, Jameel, et al.
Published: (2022)

Anti–Peptidylarginine Deiminase 4 Autoantibodies and Disease Duration as Predictors of Treatment Response in Rheumatoid Arthritis
by: Laura C. Cappelli, et al.
Published: (2024-02-01)

Peptidylarginine deiminase 2 citrullinates MZB1 and promotes the secretion of IgM and IgA
by: Benjamin Geary, et al.
Published: (2023-11-01)